Systematic review and meta-analysis comparing Manta device and Perclose device for closure of large bore arterial access.
| Autor: | Cheema T; West Suburban Medical Center, Oak Park, IL, USA., Venero C Jr; University of Kentucky College of Medicine, Lexington, KY, USA., Champaneria S; University of Kentucky College of Medicine, Lexington, KY, USA., Younas S; Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan., Hadeed Khan MA; Peshawar Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan., Anjum I; Vassar Brothers Medical Center, Poughkeepsie, NY, USA., Ijaz U; Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan., Haider S; University of Kentucky College of Medicine, Lexington, KY, USA., Akbar MS; University of Kentucky College of Medicine, Lexington, KY, USA., Abdul-Waheed M; University of Kentucky College of Medicine, Lexington, KY, USA., Saleem S; University of Kentucky College of Medicine, Lexington, KY, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The journal of vascular access [J Vasc Access] 2024 Jan 08, pp. 11297298231222314. Date of Electronic Publication: 2024 Jan 08. |
| DOI: | 10.1177/11297298231222314 |
| Abstrakt: | Data comparing MANTA device with Perclose device for large bore arterial access closure is limited. We performed meta-analysis to compare safety and efficacy of the two devices in large (⩾14 Fr sheath) arteriotomy closure post-TAVR. Relevant studies were identified via PubMed, Cochrane, and EMBASE databases until June, 2022. Data was analyzed using random effect model to calculate relative odds of VARC-2 defined access-site complications and short-term (in-hospital or 30-day) mortality. A total of 12 studies (2 RCT and 10 observational studies) comprising 2339 patients were included. The odds of major vascular complications (OR 0.99, 95% CI 0.51-1.92; p = 0.98); life threatening and major bleeding (OR 0.77, 95% CI 0.45-1.33; p = 0.35); minor vascular complications (OR 1.37, 95% CI 0.63-2.99; p = 0.43); minor bleeding (OR 0.94, 95% CI 0.57-1.56; p = 0.82); device failure (OR 0.74, 95% CI 0.49-1.11; p = 0.14); hematoma formation (OR 0.76, 95% CI 0.33-1.75; p = 0.52); dissection, stenosis, occlusion, or pseudoaneurysm (OR 1.08, 95% CI 0.71-1.62; p = 0.73) and short-term mortality (OR 1.01, 95% CI 0.55-1.84; p = 0.98) between both devices were similar. MANTA device has a similar efficacy and safety profile compared to Perclose device. Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|